Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases

REFERENCES

• Taylor M A. Indications for electroconvulsive treatment. Electoconvulsive therapy: biological foundation and clinical applications, R Abrams, W B Essman. Spectrum, New York 1982; 7–39
   Google Scholar
• Aizenberg D, Shalev A, Munitz H. The aftercare of the patient with the neuroleptic malignant syndrome. British Journal of Psychiatry 1985; 146: 317–318
   Google Scholar
• Addonizio G, Susman V L. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Journal of Clinical Psychiatry 1987; 48: 102–105
   Google Scholar
• Casey D A. Electroconvulsive therapy in the neuroleptic malignant syndrome. Convulsive Therapy 1987; 3: 278–283
   Google Scholar
• Hanin B, Lerner Y. Neuroleptic malignant syndrome. Neuroleptic Rechallenge After Electroconvulsive Therapy. Convulsive Therapy 1993; 9: 198–204
   Google Scholar
• Davis J M, Janicak P G, Sakkas P, Gilmore C, Wang Z. Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convulsive Therapy 1991; 7: 111–120
   Google Scholar
• Scheftner W A, Shulman R B. Treatment choice in neuroleptic malignant syndrome. Convulsive Therapy 1992; 8: 267–279
   Google Scholar
• Chen C C, Chen S S, Wen J K. Neuroleptic malignant syndrome and myopathy: a case report of lithium and haloperidol intoxication. Journal of the Formosan Medical Association 1985; 84: 1371–1379
   Google Scholar
• Levenson J. Neuroleptic L. malignant syndrome. American Journal of Psychiatry 1985; 142: 1137–1145
   Google Scholar
• Pope H G, Keck P E, McElroy S L. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry 1986; 143: 1227–1233
   Google Scholar
• Addonizio G, Susman V L, Roth S D. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry 1986; 143: 1587–1590
   Google Scholar
• Caroff S N, Mann S C, Lazarus A, Sullivan Neuroleptic K. malignant syndrome: diagnostic issues. Psychiatric Annals 1991; 21: 130–147
   Google Scholar
• Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Association, Washington, DC 1994; 739–742
   Google Scholar
• Powers P, Douglass T S, Waziri R. Hyperpyrexia in catatonic states. Diseases of the Nervous System 1976; 37: 359–361
   Google Scholar
• O'Toole J K, Dyck G. Report of psychogenic fever in catatonia responding to electroconvulsive therapy. Diseases of the Nervous System 1977; 38: 852–853
   Google Scholar
• Mann S C, Caroff S N, Bleier H R, Antelo R E, Un H. Electroconvulsive therapy of the lethal catatonia syndrome. Convulsive Therapy 1990; 6: 239–247
   Google Scholar
• Vitkun S A, Boccio R V, Poppers P J. Anaesthetic management of a patient with neuroleptic malignant syndrome. Journal of Clinical Anesthesia 1990; 2: 188–191
   Google Scholar
• Lotstra F, Linkowski P, Mendlewicz J. General anesthesia after neuroleptic malignant syndrome. Biological Psychiatry 1983; 18: 243–247
   Google Scholar
• Slack T, Stoudemire A. Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome. General Hospital Psychiatry 1989; 11: 365–367
   Google Scholar
• Steadman P. Treatment of hypomania following neuroleptic malignant syndrome. Biological Psychiatry 1992; 32: 104
   Google Scholar
• Sachdev P, Kruk J, Kneebone M, Kissane D. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases. Journal of Clinical Psychopharmacology 1995; 15: 365–371
   Google Scholar
• Greenberg L B, Gujavarty K. The neuroleptic malignant syndrome: review and report of three cases. Comprehensive Psychiatry 1985; 26: 63–70
   Google Scholar
• Hermesh H, Shalev A, Weizman A, Aizenberg D. Neuroleptic malignant syndrome. British Journal of Psychiatry 1986; 149: 384–385
   Google Scholar
• Lazarus A. Treatment of neuroleptic malignant syndrome with electroconvulsive therapy. Journal of Nervous and Mental Disease 1986; 174: 47–49
   Google Scholar
• Frances A, Susman V L. Managing an acutely manic 17-year-old girl with neuroleptic malignant syndrome. Hospital and Community Psychiatry 1986; 37: 771–788
   Google Scholar
• Harland C C, O'Leary M M, Winters R, Owens J, Hayes B, Melikian V. Neuroleptic malignant syndrome: a case for electroconvulsive treatment. Postgraduate Medical Journal 1990; 66: 49–51
   Google Scholar
• Jesse S S, Anderson G F. ECT in the Neuroleptic Malignant Syndrome: case report. Journal of Clinical Psychiatry 1983; 44: 186–188
   Google Scholar
• Regstein Q R, Alpert J S, Reich P. Sudden catatonic stupor with disastrous outcome. Journal of the American Medical Association 1977; 238: 618–620
   Google Scholar
• Prakash R, Leavell S R. Status epilepticus with unilateral ECT: case report. Journal of Clinical Psychiatry 1984; 45: 403–404
   Google Scholar
• Abrams R. Electroconvulsive therapy, 2nd ed. Oxford University Press, New York 1992
   Google Scholar
• Weiner R D. ECT-induced status epilepticus and further ECT. A case report. American Journal of Psychiatry 1981; 138: 1237–1238
   Google Scholar
• Hansen-Grant S, Tandon R, Maixner D. Subclinical status epilepticus following ECT. Convulsive Therapy 1995; 11: 134–138
   Google Scholar
• Hughes J R. ECT during and after the neuroleptic malignant syndrome: case report. Journal of Clinical Psychiatry 1986; 47: 42–43
   Google Scholar
• George A L, Jr, Wood C A, Jr. Succinylcholine-induced hyperkalemia complicating the neuroleptic malignant syndrome [letter]. Annals of Internal Medicine 1987; 106: 172
   Google Scholar
• Zammit G K, Sullivan T B. Thioridazine and neuroleptic malignant syndrome. Biological Psychiatry 1987; 22: 1286–1287
   Google Scholar
• Grigg J R. Neuroleptic malignant syndrome and malignant hyperthermia. American Journal of Psychiatry 1988; 145: 1175
   Google Scholar
• Keck P E, Caroff S N, McElroy S L. Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?. Journal of Neuropsychiatry and Clinical Neurosciences 1995; 7: 135–144
   Google Scholar
• Kish S J, Kleinert R, Minauf M, et al. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. American Journal of Psychiatry 1990; 147: 1358–1363
   Google Scholar
• Hermesh H, Aizenberg D, Weizman A. A successful electro-convulsive treatment of neuroleptic malignant syndrome. Acta Psychiatrica Scandinavica 1987; 75: 237–239
   Google Scholar
• Miller C E, Gilbert H, Morales O. Lethal catatonia following temporomandibular joint surgery: a case report. Journal of Oral Maxillofacial Surgery 1994; 52: 510–512
   Google Scholar
• Lazarus A, Mann S C, Carrof S N. The neuroleptic malignant syndrome and related conditions. Clinical practice series no. 6, American Psychiatric Press, Washington, DC 1989
   Google Scholar
• Sackeim H A, Devanand D P, Nobler M S. Electroconvulsive therapy. Psychopharmacology: the Fourth Generation of Progress, F E Bloom, D J Kupfer. Raven Press, New York 1995; 1123–1141
   Google Scholar
• Fink M. Lethal catatonia. Neuroleptic malignant syndrome, and catatonia. A spectrum of disorders [letter reply]. Journal of Clinical Psychopharmacology 1997; 17: 237
   Google Scholar
• Carroll B T, Taylor R E. The nondichotomy between lethal catatonia and neuroleptic malignant syndrome [letter]. Journal of Clinical Psychoparmacology 1997; 17: 235–236
   Google Scholar
• Fink M. Recognizing NMS as a type of catatonia. Neuropsychiatry, Neuropsychology and Behavioral Neurology 1995; 8: 75–76
   Google Scholar
• Taylor M A. Catatonia: a review of a behavioural neurologic syndrome. Neuropsychiatry, Neuropsychology and Behavioral Neurology 1990; 3: 48–72
   Google Scholar
• Mann S C, Caroff S N, Bleier H R, Welz W K, Kling M A, Hayashida M. Lethal catatonia. American Journal of Psychiatry 1986; 143: 1374–1381
   Google Scholar
• Goeke J E, Hagan D S, Goelzer S L, Coursin D B. Lethal catatonia complicated by the development of neuroleptic malignant syndrome in a middle-aged female. Critical Care Medicine 1991; 19: 1445–1451
   Google Scholar
• Reis R K, Schuckit M A. Catatonia and autonomic hyperactivity. Psychosomatics 1980; 21: 349–350
   Google Scholar
• Chrisstoffels J, Thiel J H. Delirium acutum, a potentially fatal condition in the psychiatric hospital. Psychiatria Neurologia Neurochirurgia 1970; 73: 177–187
   Google Scholar
• Sachdev P, Mason C, Hadzi-Pavlovic D. A case-control study of neuroleptic malignant syndrome. American Journal of Psychiatry 1997; 154: 1156–1158
   Google Scholar
• Caroff S N, Rosenberg H, Fletcher J E, Heineman-Patterson T D, Mann S C. Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. Anaesthesiology 1987; 67: 20–25
   Google Scholar
• Foster P S, Gesini E, Claudioanos C, Hopkinson K C, Denborough M A. Inositol 1,4,5-trisphosphate deficiency and malignant hyperpyrexia in swine. Lancet 1989; 2: 124–127
   Google Scholar
• Denborough M A, Collins S P, Hopkinson D L. Rhabdomyolysis and malignant hyperpyrexia. British Medical Journal 1984; 28: 1878
   Google Scholar
• Araki M, Takagi A, Higuchi I, Sugita H. Caffeine contracture in neuroleptic malignant syndrome [abstract]. Muscle and Nerve 1988; 9: 221
   Google Scholar
• Tollefson G. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia. Journal of Clinical Psychopharmacology 1982; 1: 266–270
   Google Scholar
• Scarlett J D, Zimmerman R, Berkovic S F. Neuroleptic malignant syndrome. Australian and New Zealand Journal of Medicine 1983; 13: 70–73
   Google Scholar
• Merry S N, Werry J S, Merry A F, Birchall N. The neuroleptic malignant sydndrome in an adolescent. Journal of the American Academy of Child and Adolescent Psychiatry 1986; 25: 284–286
   Google Scholar
• Geiduschek J, Cohen S A, Khan A, Cullen B F. Repeated anesthesia for a patient with neuroleptic malignant syndrome. Anesthesiology 1988; 68: 134–137
   Google Scholar
• Nelson T E, Jones E W, Bedell P M. Porcine malignant hyperthermia: a study of the triggering effects of succinylcholine. Anesthesia and Analgesia 1973; 52: 61
   Google Scholar